BACKGROUND: Plasma levels of lactate and succinate are predictors of mortality in critically injured patients in military and civilian settings. In relative terms, these metabolic derangements have been recapitulated in rodent, swine, and nonhuman primate models of severe hemorrhage. However, no direct absolute quantitative comparison has been evaluated across these species.
R ecent evidence of the poor correlation between genomic responses in mouse models of inflammatory disease and human data 1 fueled the debate about the translational clinical relevance of results obtained in animal models. Similarly, reassuring evidence from randomized clinical trials on the influence of the age of blood on transfusion outcomes mitigated the concerns raised by observations in animal models. 2 It is thus easy to understand how concerns about the translatability of observations in animal models into clinical practice may have been recently questioned in other biomedical fields, such as the field of critical care medicine. Limitations and caveats on the use of animal models in critical care medicine have been recently reviewed. 3, 4 Despite such limitations, paraphrasing George Box's famous quote, it is reasonable to wonder that, if "all-animal-models are wrong," how wrong does the model have to be not to be useful? Rodents, 5 swine, 6 and more recently, nonhuman primates 7 have been used extensively as models of hemorrhagic shock, with the goal to improve our understanding of the molecular mechanisms underlying the sequelae to the most preventable cause of death in civilian and military trauma. Recently, we 8 and others 9 identified plasma succinate as a metabolic marker of hypoperfusion and predictor of mortality in civilian and military critically injured patients. This observation expanded on the well-established role of metabolic acidosis and circulating levels of lactate as a predictor of mortality in trauma and a marker of occult shock. 10, 11 Based on observations in animal models of ischemia/ reperfusion injury, 12 we proposed that hemorrhagic hypoxemia increases circulating levels of lactate and citric acid metabolites, such as succinate, 5 because of oxygen deprivation driving uncoupling of the electron transport chain. In animal models, plasma levels of citric acid cycle metabolites begin to accumulate within 5 minutes of hemorrhagic shock. 5 These observations are consistent in all tested animal models and clinical samples, 5, 6, 13 as gleaned by relative quantitative values. However, to the best of our knowledge, no direct comparison of these models to absolute quantitative measurements of clinically relevant markers lactate and succinate in clinical cohorts has been performed. Here, we performed such comparison by exploiting a quantitative ultrahigh-pressure liquid chromatography-mass spectrometry (UHPLC-MS) approach, using stable isotope-labeled internal standards for lactate and succinate. The underlying hypothesis is that evolutionary divergence of mammals from rodents to swine, nonhuman primates and humans would influence the systemic metabolic response to severe hemorrhage, making genetically less related mammals a less reliable model for human metabolic derangements 14 in shock. Comparison of baseline and postshock values for plasma lactate and succinate were compared to inter-species measurements in rats, pigs, macaques and clinical samples. 
MATERIALS AND METHODS

Rodent Samples
Samples were collected at baseline or at 1 hour and 30 minutes through shock from Sprague/Dawley male rats (n = 16) undergoing laparotomy and severe hemorrhage to mean arterial pressure (MAP) less than 30 mm Hg, as described previously. 5 Briefly, animals weighing 407 g to 515 g (Harlan Labs, Indianapolis, IN) were anesthetized with 50 mg/kg pentobarbital sodium via intraperitoneal injection at the beginning of the model and redosed intravenously (1 mg/kg) as necessary during the procedure. One percent lidocaine injection was administered at all incision sites for analgesia. A tracheostomy was performed, and a tracheostomy tube was placed. The right femoral artery and vein were cannulated, and femoral artery catheters were connected to Pro-Paq devices (Protocol Systems, Beaverton, OR) to monitor heart rate and MAP. Nonlethal hemorrhagic shock was induced via controlled hemorrhage from the femoral artery to a MAP of 28 mm Hg to 30 mm Hg.
Swine Samples
Samples were collected at baseline or at 1 hour and 30 minutes through shock from male outbreed swine (n = 10) undergoing hemorrhage to MAP of 25 mm Hg, as described previously. 6 Male outbreed swine (50-55 kg) underwent anesthesia with ketamine (20 mg/kg) (VETone, Boise, ID) and acepromazine (0.2 mg/kg) (VETone) and xylazine (2 mg/kg) (Akorn, Decatur, IL), then were maintained on general anesthesia using isoflurane (0.5-2%) in room air, by mask. Animals underwent tracheostomy, femoral artery cannulation to measure blood pressure and induce hemorrhage. After tracheostomy, the animals were placed on mechanical ventilation to maintain O 2 saturation greater than 90%.
Nonhuman Primate Samples
Rhesus macaques used in this study were housed in compliance with the Secretary of the Navy Instruction (SECNAVINST) 3900.38C regulations. Male rhesus macaques (n = 16) weighing 11 ± 1kg underwent intubation followed by femoral artery cannulation to measure blood pressure, as described previously. 7, 15 nonhuman primates were sedated with Telazol (3.0 mg/kg; Fort Dodge Animal Health, Overland Park, KS), pre-medicated with an analgesic (Buprenex 0.03 mg/kg; Reckitt Benkiser, Slough, Berkshire, UK). Airway intubation was achieved with placement of a pediatric, size 4 mm to 5.5 mm, endotracheal tube (Rusch-Teleflex, Research Triangle Park, NC), and placed on a Figure 1 . Plasma levels of lactate (mM) in rats, pigs, nonhuman primates and critically ill patients at baseline (green) and shock (red). Mean ± standard deviations are indicated (*p <0.05; **p <0.01; ***p < 0.0001 t-test). Figure 2 . Plasma levels of succinate (μM) in rats, pigs, nonhuman primates and critically ill patients at baseline (green) and shock (red). Mean ± standard deviations are indicated (*p <0.05; **p <0.01; ***p < 0.0001, t-test).
Dräger Apollo Anesthesia Workstation (Draeger Medical Inc., Telford, PA) with volume-controlled respiration (10 mL/kg) at 12 to 15 breaths per minute, FiO 2 of 21% to 25% and isoflurane (1.0-2.0%) inhalational anesthesia. Hemorrhage was initiated by opening a stopcock in-line with the left arterial catheter allowing free-flow of blood until the MAP reached 20 mm Hg. This moment marked the beginning of the shock period, additional blood was withdrawn as needed to maintain a MAP of 20 mm Hg to 24 mm Hg until animals no longer exhibited cardiovascular compensatory responsiveness to maintain or elevate MAP (i.e., decompensation). Decompensation was defined as a spontaneous decline in an nonhuman primate's MAP to a value 75% of the MAP average over the first 60 minutes of shock. Samples were collected at baseline or at 1 hour 30 minutes through shock.
Human Samples
Human plasma samples were collected from severely injured patients enrolled at the Denver Health Medical Center, a Level I Trauma Center in Denver, Colorado (inclusion criteria: age ≥ 18; acutely injured; SBP less than 70 mm Hg at admission; exclusion criteria: visibly or verbally reported pregnant women, known prisoners, unsalvageable injuries-defined as asystolic or cardiopulmonary resuscitation before randomization; known objection to blood products; patient with opt-out bracelet, necklace, or wallet card; family member present at the scene objects to patient's enrollment in research). Samples were collected from 25 male patients showing base deficit greater than 7.5. For this analysis, the earliest time point available for each one of those patients was used, with samples being collected either in the field (<30 minutes from traumatic injury) at the arrival in the emergency department in any case less than 2 hours from shock.
Sample Extraction and UHPLC-MS Quantitation of Succinate and Lactate
Whole blood samples were collected in sodium citrate tubes, centrifuged at 1,000g for 15 minutes at 4°C and 12,600g for 6 minutes at 4°C to sort plasma from blood components, before storage at −80°C. Plasma (10 μL) was extracted in presence of 13 C 1 -lactate and 1 μM of 13 C 4 -succinate as internal standards. 5, 16 Metabolomics analyses were performed by ultrahigh-performance liquid chromatography coupled with high-resolution mass spectrometry (Vanquish-Q Exactive; Thermo Fisher, Bremen, Germany) as reported. 5, 16 Absolute quantitation was determined by integrating peak areas of the light and heavy isotopologues for lactate and succinate (matched, in each sample tested), according to the formula:
Metabolite AbsoluteQuant = (Integrated Peak Area Light /Integrated Peak Area Heavy ) Â Concentration Heavy Â 25 (Dilution factor).
Absolute levels of lactate were determined by first subtracting the naturally occurring 13 C 1 -lactate (3.3% abundance of the parent 13 C-lactate) from the observed 13 C 1 -lactate signal. Description and analytical validation of the method has been described recently. 16 Statistical analyses (including, as appropriate, paired and unpaired t-test or analysis of variance (ANOVA) of lactate and succinate measurements) were performed through GraphPad Prism 5.0.
RESULTS
Plasma lactate and succinate levels were measured in rats, pigs, macaques, and clinical patients by UHPLC-MS (means ± standard deviations are graphed in the dot-plots in Figs. 1 and 2 ). Baseline levels of lactate differed significantly (p < 0.001) in rats compared with pigs, macaques, and humans (Fig. 1) . Though not reaching significance, baseline plasma lactate levels in pigs were almost twofold higher in pigs than in macaques and humans (Fig. 3) . Postshock levels of lactate were not significantly different between pigs, macaques, and humans. On the other hand, postshock rats had the highest increases in plasma lactate (Fig. 3) , in a model designed to obtain comparable final MAP (<30 mm Hg) to hemorrhaged pigs or macaques. Similarly, basal and postshock levels of succinate in rats were significantly higher than those measured in the other groups (Fig. 4) . Postshock levels of succinate in pigs were significantly lower than humans (Fig. 4) , whereas no significant differences were observed between basal or postshock succinate levels in macaques and humans. Shock/baseline ratios for plasma lactate and succinate were comparable in pigs, macaques, and humans, whereas statistically different in rats (Figs. 3 and 4) . Postshock levels of plasma succinate and lactate were positively and significantly correlated in all tested groups (Fig. 5) . Exponential increases in plasma succinate were observed in rats, macaques and humans with lactate levels greater than 5 mM (Fig. 5) .
DISCUSSION
After recent comprehensive reviews on animal models in trauma, 3, 4 in the present article, we provide the first transspecies comparative quantitative analysis of posthemorrhagic shock levels of plasma lactate and succinate. Notably, initial levels of plasma lactate and succinate were significantly higher at baseline in rats in comparison to all the other tested animals and clinical patients. However, it is worth noting that baseline levels are affected by anesthesia, catheter insertion, and in rats more than in the other larger mammals investigated here, initial blood volume loss for sampling (as we previously reported 5 ), all factors that may affect the comparability of results across species. Postshock levels of succinate, as well as shock/baseline fold-changes for this metabolite, were significantly different in rats and pigs in comparison to macaques and humans. This is relevant in light of the recent appreciation of the role of succinate as a predictor of mortality at least comparable and potentially more specific than lactate in critically ill patients. 8 Postshock levels of circulating lactate and (where reported in the literature) succinate are comparable to previous observations in rats, 17 pigs, 18 and macaques. 19 However, greater than 150-μM levels of postshock succinate have been reported in a cohort of severely injured military patients, 9 suggesting that the clinical cohort investigated here was not suffering from extreme tissue hypoxia.
The present study has several limitations. Varying degrees of shock were achieved across animals, despite targeting a final MAP consistently less than 30 mm Hg. Similarly, clinical cohort consists of patients with varying degrees of bleeding as well as tissue injury, and blood sampling was not perfectly matched to the animal experiments. In this view, it is worth noting that comparability of human data from patients with circulating lactate greater than 6 mM highlighted similarities to rats and macaques in terms of simultaneous exponential increases of plasma succinate above 200 μM. Of note, in animals and clinical setting, postshock circulating levels of lactate may also be confounded, respectively, by different anesthetics and extra loading (e.g., through the administration of lactated Ringer), reduced hepatic clearance and postshock catecholamine signaling influencing pyruvate dehydrogenase activity, and thus pyruvate shuttling to the Krebs cycle. 20 Moreover, this analysis was sex-biased, in that all animals and patients were male.
In sum, from the present study, it is evident that baseline levels of lactate and succinate in plasma become increasingly comparable across mammals the closer we got (in evolutionary terms) to humans (rodents < pigs < macaques < humans), as hypothesized. Shock/baseline ratios were comparable across all tested species for key metabolites, such as lactate, suggesting that small animals may still represent a valuable model to test specific hypotheses in trauma. Still, despite confounders limiting the generalization of the present study, we suggest that larger mammals may represent a better model than smaller animals when investigating metabolic derangements secondary to severe hemorrhage.
